Samarth Kulkarni Insider Trading
Get free email notifications about insider trading for Samarth Kulkarni.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Samarth Kulkarni. Samarth Kulkarni is a Chief Business Officer in CRISPR Therapeutics AG ($CRSP) and an Chief Executive Officer in CRISPR Therapeutics AG ($CRSP) and a Please See Remarks in CRISPR Therapeutics AG ($CRSP) and a Director in Black Diamond Therapeutics, Inc. ($BDTX) and a Director in Repare Therapeutics Inc. ($RPTX).
Address: C/O CRISPR THERAPEUTICS, INC. 200 SIDNEY ST. CAMBRIDGE 02139 MA
Companies in which Samarth Kulkarni is an Insider
Black Diamond Therapeutics, Inc.
Trading Symbol: BDTXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Samarth Kulkarni: Director
Holdings: 0 shares
Latest Transaction: Jun 22 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CRISPR Therapeutics AG
Trading Symbol: CRSPIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Samarth Kulkarni: Chief Executive Officer, Please See Remarks, Chief Business Officer
Holdings: 217,719 shares
Current Value: $3,429,074
Latest Transaction: Jun 17 2021
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Repare Therapeutics Inc.
Trading Symbol: RPTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Samarth Kulkarni: Director
Holdings: 0 shares
Latest Transaction: May 14 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Samarth Kulkarni
Sentiment: All, BDTX, CRSP, RPTX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2021 | BDTX | Black Diamond Ther ... | Kulkarni Samarth | Director | Option Exercise | A | 12.55 | 15,000 | 188,250 | 15,000 | |
Jun 17 2021 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Option Exercise | M | 12.57 | 30,000 | 377,100 | 63,333 | |
Jun 17 2021 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Sell | S | 127.51 | 3,488 | 444,755 | 187,719 | 191.2 K to 187.7 K (-1.82 %) |
Jun 17 2021 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Sell | S | 126.86 | 16,129 | 2,046,125 | 191,207 | 207.3 K to 191.2 K (-7.78 %) |
Jun 17 2021 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Sell | S | 125.39 | 10,383 | 1,301,924 | 207,336 | 217.7 K to 207.3 K (-4.77 %) |
Jun 17 2021 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Buy | M | 12.57 | 30,000 | 377,100 | 217,719 | 187.7 K to 217.7 K (+15.98 %) |
May 14 2021 | RPTX | Repare Therapeutic ... | Kulkarni Samarth | Director | Option Exercise | A | 32.44 | 21,000 | 681,240 | 21,000 |